Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01463345

Blood Conservation in Cardiac Surgery

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Hackensack Meridian Health · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to examine the safety of two different hemoglobin (Hgb)-based transfusion triggers in patients post cardiac surgery.

Detailed description

Nearly 20% of blood transfusions in the United States are given to in patients undergoing cardiac surgery. Despite the many blood conservation techniques that are available, safe, and efficacious for patients, many of these operations continue to be associated with significant amounts of blood usage. We believe that transfusion protocols which employ specific guidelines for transfusion can decrease blood product usage and improve outcomes for patients undergoing cardiac surgery. Our goal is to demonstrate that a carefully chosen trigger can achieve better outcomes. Our hypothesis is that a transfusion trigger of Hgb 7.5 g/dl will lead to decreased utilization of blood transfusions and will have many positive effects on the patients post cardiac surgery in addition to substantial cost savings. We will use an evidence based approach to observe the relative safety of a conservative transfusion trigger (7.5 g/dl) as compared to a more liberal trigger (9.0 g/dl). We will also study the effect of blood conservation on the incidence of transfusion-related complications such as transfusion related lung injury (TRALI) and infectious complications as well as length of hospital stay, cost and ventilator time.

Conditions

Interventions

TypeNameDescription
OTHERBlood transfusionConservative transfusion arm: Subjects randomized to the conservative transfusion arm will receive transfusions of PRBCs post-surgery only when their Hgb level measures \< 7.5 g/dl. Blood products should be given to maintain Hgb levels \>7.5 g/dl.
OTHERBlood transfusionLiberal transfusion arm: Subjects randomized to the liberal transfusion arm will receive transfusions of PRBCs post-surgery only when their Hgb level measures \< 9.0 g/dl. Blood products should be given to maintain Hgb levels \> 9.0 g/dl.

Timeline

Start date
2011-11-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2011-11-01
Last updated
2018-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01463345. Inclusion in this directory is not an endorsement.

Blood Conservation in Cardiac Surgery (NCT01463345) · Clinical Trials Directory